1. Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol Z1K. (October 2022) Authors: Kalinsky, K.; Zihan, W.; McCourt, C.; Mitchell, E.P.; Wright, J.J.; Doyle, L.A.; Gray, R.J.; Wang, V.; McShane, L.M.; Rubinstein, L.V.; Patton, D.; Williams, P.M.; Hamilton, S.R.; Conley, B.A.; Arteaga, C.A.; Harris, L.N.; O'Dwyer, P.J.; Chen, A.P.; Flaherty, K.T. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗